v3.26.1
Shareholders' Equity (Tables)
3 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Equity [Abstract]      
Common Stock Issuances Exelon issued the following shares of Common stock in the second quarter of 2026:
Effective Period
Shares Issued
(in millions)
Weighted-Average Net Price
Net Proceeds (a)
(in millions)
Q2 2026 (b)
8.7$44.03 $382 
_________
(a)Proceeds were used for general corporate purposes.
(b)In Q2 2026, Exelon settled all forward sale agreements with a November 16, 2026 maturity date and a portion of the forward sale agreements with December 15, 2026 and July 30, 2027 maturity dates that were entered into by various forward sellers under the ATM program as outlined below.
   
Schedule of Forward Contracts Indexed to Issuer's Equity   The following forward sale agreements were entered into under Exelon’s ATM program in the first quarter of 2026:
Effective PeriodShares Available
(in millions)
Weighted-Average Net PriceMaturity Date
Q1 20265.4$47.67 July 30, 2027
Q1 20266.4$48.68 September 2, 2027
 
ATM Forward Contracts Not Settled    
Additionally, the following forward sale agreements were entered into during the twelve months ended 2025 under Exelon’s ATM program and were not settled as of December 31, 2025:
Effective PeriodShares Available
(in millions)
Weighted-Average Net PriceMaturity Date
Q2 20253.6$43.17 November 16, 2026
Q3 202511.5$43.73 December 15, 2026
Q4 20250.8$45.42 December 15, 2026